Rigaku Announce New President & COO
News Apr 07, 2015
Rigaku Corporation has announced that, as of April 1, 2015, Mr. Yoichi Yokomizo succeeded Mr. Wes Hardenburg to become President and Chief Operating Officer (COO) of Rigaku Americas Holding Company, Inc. (RAH).
Mr. Hikaru Shimura, Rigaku Corporation Chairman and CEO, said that this change was made "in order to better encourage growth throughout the Rigaku Group and to ensure that we are able to effectively pursue our mission of contributing to the enhancement of humanity through scientific and technological development … his presence will facilitate better communication and a stronger connection between the U.S.-based Rigaku businesses and Rigaku Corporation in Japan.”
Prior to this assignment, Mr. Yokomizo served as Executive VP and General Manager of Rigaku’s Global Sales and Marketing Group. Previous to joining Rigaku in 2012, Mr. Yokomizo amassed a wealth of experience in managing organizations with strong leadership as an “Innovation Leader.”
Former positions included being EVP/CIO for Lawson, Inc., President and CEO of i2 Technologies (Japan) and General Manager for IT strategy at Mitsubishi Corporation (Japan). Mr. Yokomizo has B.S. and M.S. degrees in mechanical engineering from Keio University and a M.B.A. degree from the Massachusetts Institute of Technology (MIT).
As of April 1, 2015, Mr. Wes Hardenburg resigned his position with Rigaku to pursue other interests. Mr. Hardenburg commented that “it was with great pleasure and an honor to work with the team members of Rigaku since December 1991 … I am looking forward to hearing about Rigaku achieving its goals and wishing a prosperous and exciting future for all.”
Raman Spectroscopy Aids Advancement of Spintronic DevicesNews
Researchers used an unconventional approach, employing Raman spectroscopy with an ultraviolet laser instead of conventional visible light lasers, to improve understanding of nickel oxide crystals. This work could have important implications for development of spintronic devices for memory storage and information processing.READ MORE
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE
Marburg Virus: Workings of the First Promising Treatment RevealedNews
Scientists have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus. The research builds on previous studies showing that an antibody called MR191 can neutralize Marburg—though no one knew exactly how it targeted the virus.READ MORE